1. Home
  2. PW vs TOVX Comparison

PW vs TOVX Comparison

Compare PW & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PW
  • TOVX
  • Stock Information
  • Founded
  • PW 1967
  • TOVX 2001
  • Country
  • PW United States
  • TOVX United States
  • Employees
  • PW N/A
  • TOVX N/A
  • Industry
  • PW Real Estate Investment Trusts
  • TOVX Biotechnology: Pharmaceutical Preparations
  • Sector
  • PW Real Estate
  • TOVX Health Care
  • Exchange
  • PW Nasdaq
  • TOVX Nasdaq
  • Market Cap
  • PW 3.9M
  • TOVX 3.8M
  • IPO Year
  • PW N/A
  • TOVX 2006
  • Fundamental
  • Price
  • PW $1.14
  • TOVX $0.44
  • Analyst Decision
  • PW
  • TOVX Hold
  • Analyst Count
  • PW 0
  • TOVX 1
  • Target Price
  • PW N/A
  • TOVX N/A
  • AVG Volume (30 Days)
  • PW 10.9K
  • TOVX 236.2K
  • Earning Date
  • PW 08-06-2025
  • TOVX 08-12-2025
  • Dividend Yield
  • PW N/A
  • TOVX N/A
  • EPS Growth
  • PW N/A
  • TOVX N/A
  • EPS
  • PW N/A
  • TOVX N/A
  • Revenue
  • PW $3,001,057.00
  • TOVX N/A
  • Revenue This Year
  • PW N/A
  • TOVX N/A
  • Revenue Next Year
  • PW N/A
  • TOVX N/A
  • P/E Ratio
  • PW N/A
  • TOVX N/A
  • Revenue Growth
  • PW 71.26
  • TOVX N/A
  • 52 Week Low
  • PW $0.63
  • TOVX $0.40
  • 52 Week High
  • PW $2.75
  • TOVX $7.37
  • Technical
  • Relative Strength Index (RSI)
  • PW 54.58
  • TOVX 36.91
  • Support Level
  • PW $1.09
  • TOVX $0.42
  • Resistance Level
  • PW $1.14
  • TOVX $0.46
  • Average True Range (ATR)
  • PW 0.03
  • TOVX 0.03
  • MACD
  • PW -0.00
  • TOVX 0.02
  • Stochastic Oscillator
  • PW 88.14
  • TOVX 32.00

About PW Power REIT (MD)

Power REIT is an internally managed real estate investment trust (REIT) that owns a portfolio of real estate assets related to transportation, energy infrastructure, and Controlled Environment Agriculture (CEA) in the United States. Its investment portfolio comprises solar farm lands, railroad real estate, and various Controlled Environment Agriculture properties in the form of greenhouses for the cultivation of food and cannabis. In addition, the company is focused on opportunities in the form of investing in distressed situations, including debt and other types of secured interests in real estate, distressed properties, and real estate-related companies.

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Share on Social Networks: